Results for tag: "Endomyocardial Biopsy"

The Endomyocardial Biopsy (EMB) market is a subset of the larger Surgical Procedures market. It is a minimally invasive procedure used to diagnose and monitor heart conditions. During the procedure, a small sample of tissue is taken from the heart muscle and examined for signs of disease. The procedure is typically performed in a hospital or clinic setting, and is usually done under general anesthesia. The EMB market is driven by the increasing prevalence of cardiovascular diseases, as well as the need for accurate diagnosis and monitoring of these conditions. Technological advancements in the field have also contributed to the growth of the market, as they have enabled more accurate and efficient diagnosis. Some of the major players in the EMB market include Medtronic, St. Jude Medical, Boston Scientific, and Abbott Laboratories. These companies offer a range of products and services related to EMB, including catheters, guidewires, and other medical devices. Show Less Read more